Group items tagged

Almost 80% of all antibiotics in the United States aren't taken by people. They're given to cows, pigs, and chickens to make them grow more quickly or as a cheap alternative to keeping them healthy. These drugs could give rise to superbugs-bacteria that can't be treated with modern medicine-and things are only getting worse. In 2013, more than 131,000 tons of antibiotics were used in food animals worldwide; by 2030, it will be more than 200,000 tons. In a paper published today in Science, epidemiologist Thomas Van Boeckel of the Swiss Federal Institute of Technology in Zurich and colleagues outline the growing threat-and what can be done about it. Boeckel spoke to us about his team's work. This interview has been edited for clarity and length.

The threat of antibiotic resistance has become so dire that the United Nations General Assembly is holding a meeting to discuss it this month in New York City. Although WHO has been sounding the alarm on antibiotic resistance for years, this month's high-level U.N. meeting represents only the fourth time in the international body's history that its General Assembly-a global deliberative body that primarily grapples with issues like war and economics-has held a meeting to tackle a health topic.

Researchers from Emory University and the University of Iowa found that extracts from the Brazilian peppertree, which traditional healers in the Amazon have used for hundreds of years to treat skin and soft-tissue infections, have the power to stop methicillin-resistant Staphylococcus aureus (MRSA) infections in mice.

A year since launching the international partnership, the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, CARB-X ,announced its second round of antibiotic research and development funding, awarding seven projects in six countries - two in the United States, and one each in France, India, Switzerland, Ireland and the United Kingdom.

ROME (Thomson Reuters Foundation) - If drug-resistant infections in people and animals are allowed to spread unchecked, some 28 million people will fall into poverty by 2050, and a century of progress in health will be reversed, the World Bank said on Monday. By 2050, annual global GDP would fall by at least 1.1 percent, although the loss could be as much as 3.8 percent - the equivalent of the 2008 financial crisis - the Bank said in a report released ahead of a high-level meeting on the issue at the United Nations in New York this week.

"We risk being in a post-antibiotic world," said Thomas Frieden, director of the U.S. Centers for Disease Control and Prevention, referring to the urinary tract infection of a 49-year-old Pennsylvania woman who had not traveled within the prior five months. Frieden, speaking at a National Press Club luncheon in Washington, D.C., said the bacteria was resistant to colistin, an antibiotic that is reserved for use against "nightmare bacteria."

Department of Defense researchers disclosed Thursday in a report placed online by the journal Antimicrobial Agents and Chemotherapy that a 49-year-old woman who sought medical care at a military-associated clinic in Pennsylvania last month, with what seemed to be a urinary tract infection, was carrying a strain of E. coli resistant to a wide range of drugs. That turned out to be because the organism carried 15 different genes conferring antibiotic resistance, clustered on two "mobile elements" that can move easily among bacteria. One element included the new, dreaded gene mcr-1.

10:04 video, Don't panic! But you should really know about antibiotic-resistant bacteria, aka super bugs. They're here, and they're doing very well, thank you. SciShow explains what they are, how they're getting around our best drugs, and what science (and you) can do to help.

7:23 video Are we entering the post-antibiotic era? Antibiotic-resistant bacteria are on the rise, with millions of infections reported every year and thousands of deaths. How does antibiotic resistance work? How did we get here? And what can we do in the future to make sure that papercuts don't spell a death sentence?

This case study presents the story of Phil, an undergraduate majoring in biology, whose Russian cousin Dimitri has contracted tuberculosis (TB) from inmates at the prison where he works.  Phil learns that his cousin's failure to complete his antibiotic regimen likely contributed to the evolution of antibiotic-resistant TB in his body.  Phil consults with his friend Stacy, and together they try to understand Dimitri's condition by applying what they are learning in their genetics lab experiment about the role of random mutation in bacterial evolution (including the development of antibiotic resistance) through Luria- Delbrück fluctuation analysis. The same analysis includes calculation of the mutation rate, which Phil realizes is sufficient to cause MRSA and other antibiotic-resistant infections. This case study was originally developed for concurrent use in freshman/sophomore-level genetics, elementary statistics, and precalculus. However, it is also very appropriate for courses in introductory biology, evolutionary biology, and biostatistics. The teaching notes discuss various ways to run the case depending on the mathematics and biology background of students.